Clinical Trial Update: Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ) [Phase 2]

View source ↗

Summary

A Phase 2 randomized proof-of-concept study evaluating the efficacy of a psilocybin and trazodone combination for treatment-resistant depression; the trial stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• Psilocybin (psilocybin)
• Trazodone (trazodone)

Snippet

Sponsor: Centre Hospitalier St Anne | Conditions: Depression - Major Depressive Disorder, Treatment-resistant Depression (TRD) | Phase 2 | Status: NOT_YET_RECRUITING